Your browser doesn't support javascript.
loading
Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation.
Malysz, Jozef; Talamo, Giampaolo; Zhu, Junjia; Clarke, Loren E; Bayerl, Michael G; Ali, Liaqat; Helm, Klaus F; Chung, Catherine G.
Afiliación
  • Malysz J; Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Talamo G; Department of Internal Medicine, Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Zhu J; Cancer Institute, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Clarke LE; Dermatology Unit, Myriad Genetics Laboratories Inc, Salt Lake City, Utah.
  • Bayerl MG; Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Ali L; Department of Dermatology, Wayne State University and Pinkus Dermatopathology, Detroit, Michigan.
  • Helm KF; Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania; Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Chung CG; Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania; Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Electronic address: cchung1@hmc.psu.edu.
J Am Acad Dermatol ; 74(5): 878-84, 2016 May.
Article en En | MEDLINE | ID: mdl-26874821
BACKGROUND: Disease-specific skin lesions are rare in patients with multiple myeloma (MM). OBJECTIVE: We sought to further characterize the clinical and pathologic features of patients with cutaneous involvement with MM. METHODS: We identified 13 patients with cutaneous lesions of MM. RESULTS: Cutaneous lesions consisted of pink, red, and violaceous papules, nodules, and/or plaques that varied in size. Histopathology revealed atypical plasma cells with occasional plasmablastic features. MM had aggressive biologic features and was at an advanced stage in the majority of patients. Despite aggressive management, including chemotherapy and stem-cell transplantation, most patients died of progressive disease within a few months after the development of cutaneous lesions. LIMITATIONS: The study group was relatively small. CONCLUSIONS: Cutaneous involvement with MM is associated with aggressive biologic behavior and short survival.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Neoplasias Cutáneas / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Neoplasias Cutáneas / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2016 Tipo del documento: Article